Related Experiment Video
Updated: Dec 6, 2025

Formulating and Characterizing an Exosome-based Dopamine Carrier System
Published on: April 4, 2022
Exosomes: A Novel Therapeutic Paradigm for the Treatment of Depression
Shvetank Bhatt1, Jovita Kanoujia1, Arghya Kusum Dhar2
1Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), Gwalior-474005, India.
Abstract:
Extracellular vesicles (EVs) of endocytic origin are known as exosomes. These vesicles are released by cells and are found in biofluids, such as saliva, urine, and plasma. These vesicles are made up of small RNA, DNA, proteins, and play a vital role in many physiological processes. In the central nervous system (CNS), they participate in various physiological processes such as stress of nerve cells, communication between the cells, synaptic plasticity, and neurogenesis. The role of exosomes in depression needs to be explored further. It is known that exosomes can cross the blood brain barrier (BBB), which is made up of glial cells astrocytes. One of the advantages of these vesicles is that they are able to transfer macromolecules like DNA, protein, mRNAs, and miRNAs to recipient cells. This review focuses on the potential role of exosomes in depression and their utilization as a treatment option or diagnostic tool of depression.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Electroconvulsive Therapy
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents

